Mohyuddin GR - Search Results

1

Trends in diversity of participants in dermatology clinical trials over time: A systematic review.

Ferguson JE, Vetos D, Ho BV, Aziz M, Lee WM, Mohyuddin GR, Prouty M. Ferguson JE, et al. Among authors: mohyuddin gr. J Am Acad Dermatol. 2022 Jun;86(6):1403-1405. doi: 10.1016/j.jaad.2021.05.052. Epub 2021 Jun 6. J Am Acad Dermatol. 2022. PMID: 34090958 No abstract available.

2

Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma.

Abdallah AO, Mahmoudjafari Z, Ahmed N, Cui W, Shune L, McGuirk J, Mohan M, Mohyuddin GR, Afrough A, Alkharabsheh O, Atrash S. Abdallah AO, et al. Among authors: mohyuddin gr. Eur J Haematol. 2023 Jun;110(6):626-632. doi: 10.1111/ejh.13942. Epub 2023 Feb 21. Eur J Haematol. 2023. PMID: 36752328

3

Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activity.

Sengar M, Hopman WM, Mohyuddin GR, Goodman AM, Gyawali B, Mukherji D, Hammad N, Pramesh CS, Aggarwal A, Sullivan R, Booth CM. Sengar M, et al. Among authors: mohyuddin gr. Ecancermedicalscience. 2023 Jun 8;17:1558. doi: 10.3332/ecancer.2023.1558. eCollection 2023. Ecancermedicalscience. 2023. PMID: 37396096 Free PMC article.

4

A critical appraisal of the ATLAS trial of maintenance therapy for multiple myeloma: end points, censoring and equipoise.

Mohyuddin GR, Meirson T. Mohyuddin GR, et al. Nat Rev Clin Oncol. 2023 Nov;20(11):735-736. doi: 10.1038/s41571-023-00801-x. Nat Rev Clin Oncol. 2023. PMID: 37433885 No abstract available.

5

The story of the development of generic lenalidomide: How one company thwarted the Hatch-Waxman Act to generate billions of dollars in revenue.

Beechinor RJ, Mohyuddin GR, Mitchell DE, Aaron D, Mahmoudjafari Z. Beechinor RJ, et al. Among authors: mohyuddin gr. J Cancer Policy. 2023 Dec;38:100446. doi: 10.1016/j.jcpo.2023.100446. Epub 2023 Sep 28. J Cancer Policy. 2023. PMID: 37777010 Review.

6

Financial Toxicity in Oncology, More Unanswered Questions.

Beechinor RJ, Mahmoudjafari Z, Mohyuddin GR. Beechinor RJ, et al. Among authors: mohyuddin gr. J Clin Oncol. 2023 Oct 1;41(28):4600-4601. doi: 10.1200/JCO.23.00915. Epub 2023 Jul 17. J Clin Oncol. 2023. PMID: 37459577 No abstract available.

7

Detecting Selection Bias in Observational Studies-When Interventions Work Too Fast.

Mohyuddin GR, Prasad V. Mohyuddin GR, et al. JAMA Intern Med. 2023 Sep 1;183(9):897-898. doi: 10.1001/jamainternmed.2023.2067. JAMA Intern Med. 2023. PMID: 37306983

8

Quality of content reporting on two major oncology media websites: OncLive and Targeted Oncology.

Sharma N, Wayant C, Neupane K, Lenka J, Berger K, Goodman AM, Booth CM, Prasad V, Mohyuddin GR. Sharma N, et al. Among authors: mohyuddin gr. J Cancer Policy. 2023 Jun;36:100411. doi: 10.1016/j.jcpo.2023.100411. Epub 2023 Feb 10. J Cancer Policy. 2023. PMID: 36773798

9

The promise and harms of screening for plasma cell dyscrasias.

Mohyuddin GR, Chakraborty R, Cliff ERS. Mohyuddin GR, et al. Br J Haematol. 2023 Mar;200(6):704-707. doi: 10.1111/bjh.18634. Epub 2023 Jan 10. Br J Haematol. 2023. PMID: 36626939 Review.

10

Subgroups and precision in myeloma.

Ouchveridze E, Booth C, Mohyuddin GR. Ouchveridze E, et al. Among authors: mohyuddin gr. J Cancer Policy. 2023 Mar;35:100407. doi: 10.1016/j.jcpo.2023.100407. Epub 2023 Jan 22. J Cancer Policy. 2023. PMID: 36696948 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page